Timpka, Jonathan http://orcid.org/0000-0002-2577-8607
Dahlström, Örjan
Nilsson, Maria H. http://orcid.org/0000-0002-6580-6721
Iwarsson, Susanne http://orcid.org/0000-0002-6670-7952
Odin, Per
Funding for this research was provided by:
This investigator-initiated study was supported by AbbVie through a grant to Professor Per Odin.
Article History
Received: 30 December 2022
Accepted: 20 April 2023
First Online: 8 May 2023
Ethical review
: The study was approved by the Swedish Ethical Review Authority (Dnr: 2019-02820). No informed consent was collected from participants as it is not required by Swedish law for this type of study.
: J.T. has received funding from the Swedish National Government and County Councils through the ALF agreement, the Swedish Parkinson Foundation, and the Elsa Schmitz Foundation, and has received compensation for consultancies from AbbVie, TransPerfect, and the Swedish National Board of Health and Welfare, as well as royalties from UNI-MED Verlag. Ö.D. has received funding from Faculty of Arts and Sciences, Linköping University. M.N. was funded by MultiPark, the Strategic Research Area in neuroscience at Lund University, Lund, Sweden. S.I. has received honoraria from Karolinska Institutet and Swedish Agency for Participation. She has received research funding from Ribbingska Foundation in Lund, Swedish Research Council; Swedish Research Council for Health, Working Life and Welfare (Forte); Swedish Research Council for Sustainable Development (Formas), NEURO Sweden, Family Kamprad Foundation, LMK Foundation, Lund University, Lund University Innovation System, Helsingborg City Competence Foundation. P.O. has received funding from AbbVie, Lund University Medical Faculty, MultiPark, the Swedish Parkinson Foundation, Region Skåne, and Åhlén Foundation. He has received honoraria for lectures and expert advice from AbbVie, Bial, Britannia, Ever Pharma, Global Kinetics, Lobsor, Nordic Infucare, Stada, and Zambon. He has received royalties from UNI-MED Verlag.